Pharmaceuticals news FT.com

AstraZeneca rejected close to £80mn in state support for cancelled Speke factory

UK company raised NHS rejection of its new breast cancer drug and drug pricing mechanism during negotiations

Feb 9, 2025 - 21:46
 0
AstraZeneca rejected close to £80mn in state support for cancelled Speke factory
UK company raised NHS rejection of its new breast cancer drug and drug pricing mechanism during negotiations
Read More

Tags:

Previous Article

Merck shares sink 11% after vaccine shipments to China halted

Next Article

AstraZeneca ditches plan to build £450mn UK vaccine plant

Related Posts

UK promises rapid review of NHS drug-pricing rebate

UK promises rapid review of NHS drug-pricing rebate

Apr 3, 2025  0

Ex DeepMind scientist launches AI drug discovery venture

Ex DeepMind scientist launches AI drug discovery venture

Feb 13, 2025  0

Investors lose their appetite for the obesity trade

Investors lose their appetite for the obesity trade

Feb 9, 2025  0